Mylan - Positive Investment Alert

Mylan - Positive Investment Alert


Mylan stock price has corrected about 20% soon after announcing that it intends to buy Europe based specialty pharma company - Meda. The price offered is a 90% premium to Meda's last traded price.



from Biotech News